Department of Dermatology of First Affiliated Hospital of PLA General Hospital, Beijing, 100048, China.
Photodiagnosis Photodyn Ther. 2019 Mar;25:106-110. doi: 10.1016/j.pdpdt.2018.09.012. Epub 2018 Nov 19.
To observe the clinical efficacy and therapeutic response of Hemoporfin photodynamic therapy (PDT) for infant facial port-wine stains (PWS).
Hemoporfin PDT was used to treat 100 cases of infant facial PWS. After receiving Hemoporfin skin test, the cases with a negative skin test result were intravenously injected with Hemippofen (5 mg/kg) and irradiated under 532 nm LED green light. After treatment, a follow-up visit was paid through WeChat and Dermlink PWS consulting platform, in order to observe the therapeutic response and clinical efficacy.
The follow-up visit showed an effective rate of 98%, including 85 cases of itching (85%), 100 cases of edema (100%), 89 cases of purpura-like change (89%), 33 cases of crust (33%), 2 cases of hyperpigmentation (2%) and 2 cases of scars (2%), with no allergy and other systematic adverse reaction.
Hemoporfin PDT has a high clinical efficacy and response rate in treating infant facial PWS, with slight adverse reactions.
观察血卟啉光动力疗法(PDT)治疗婴幼儿面部葡萄酒色斑(PWS)的临床疗效和治疗反应。
采用血卟啉 PDT 治疗 100 例婴幼儿面部 PWS。在进行血卟啉皮肤试验后,对皮肤试验结果阴性的病例静脉注射血卟啉(5mg/kg),并在 532nm LED 绿光下进行照射。治疗后,通过微信和 Dermlink PWS 咨询平台进行随访,以观察治疗反应和临床疗效。
随访显示有效率为 98%,其中瘙痒 85 例(85%)、水肿 100 例(100%)、紫癜样改变 89 例(89%)、结痂 33 例(33%)、色素沉着 2 例(2%)和瘢痕 2 例(2%),无过敏等全身不良反应。
血卟啉 PDT 治疗婴幼儿面部 PWS 临床疗效高,反应率高,不良反应轻微。